Re: VRTX IDIX ANDS / non-nuke polymerase inhibitors
VRTX is playing is cards close to the vest on the acquired molecules, but on today’s CC Kurt Graves let on that VCH-222, the lead ViroChem compound, binds to the “thumb” site on the HCV polymerase. This distinguishes VCH-222 from ANA598 and IDX375, which bind to the “palm” site.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”